The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

Two oral fluoropyrimidine therapies have been introduced for metastatic colorectal cancer. One is a 5-fluorouracil pro-drug, capecitabine; the other is a combination of tegafur and uracil administered together with leucovorin. The purpose of this study was to compare the clinical effectiveness and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, S E, Kaltenthaler, E, Cowan, J, Marples, M, Orr, B, Seymour, M T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360498/
https://www.ncbi.nlm.nih.gov/pubmed/16804526
http://dx.doi.org/10.1038/sj.bjc.6603215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360498/
https://www.ncbi.nlm.nih.gov/pubmed/16804526
http://dx.doi.org/10.1038/sj.bjc.6603215

Ejemplares similares